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Commentary
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Introduction
Neuroscience presents important neuroethical considerations. Human neuroscience demands focused application of the
core research ethics guidelines set out in
documents such as the Belmont Report.
Various mechanisms, including institutional review boards (IRBs), privacy rules,
and the Food and Drug Administration,
regulate many aspects of neuroscience
research and many articles, books, workshops, and conferences address neuroethics. (Farah, 2010; https://bioethicsarchive.
georgetown.edu/pcsbi/studies.html; http://
www.neuroethicssociety.org/annualmeeting). However, responsible neuroscience research requires continual dialogue
among neuroscience researchers, ethicists,
philosophers, lawyers, and other stakeholders to help assess its ethical, legal, and
societal implications. The Neuroethics
Working Group of the National Institutes
of Health (NIH) Brain Research through
Advancing Innovative Neurotechnologies
(BRAIN) Initiative, a group of experts providing neuroethics input to the NIH BRAIN
Initiative Multi-Council Working Group,
seeks to promote this dialogue by pro-
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posing the following Neuroethics Guiding Principles (Table 1).
Two general points frame these principles. First, pursuing neuroscience research is an ethical imperative. Brain
diseases and disorders cause immense suffering and have a major economic impact
worldwide. Our ability to intervene medically is hampered by limited understanding of brain function and of how brain
circuits go awry in disorders such as
dementia, chronic pain, depression, addiction, and autism. The NIH BRAIN Initiative focuses on developing new tools
and neurotechnologies to transform understanding of brain function in health
and disease. That knowledge is critical to
enabling novel therapies for brain disorders and thus is ethically compelled.
Second, neuroethics is vital to neuroscience research. The consideration of
ethical, legal, and societal implications of
neuroscience research facilitates progress in neuroscience and helps to ensure
that neuroscientific advancements support human well-being. Integrating neuroethics into the NIH BRAIN Initiative
serves the interests of all involved stakeholders. Success requires collaborative input from many disciplines, including
neuroscience, medicine, bioethics, philosophy, law, and others.
We intend these principles to serve
as points to consider for researchers,
IRBs, and others involved in the conduct of BRAIN-funded research. They
also may be useful to NIH leadership
and advisory groups when considering future research directions (http://doi.org/

10.1523/JNEUROSCI.2091-18.2018) and
likely to people and groups beyond the
NIH BRAIN Initiative.

Neuroethics Guiding Principles
1. Make assessing safety paramount
Human subjects protections place the
highest priority on research participant
safety, including physical, psychological,
and emotional consequences of research
participation, in the short, intermediate,
and long term. This is particularly important in neuroscience research because the
complexity of the human brain lends unpredictability to outcomes of intervention
and may heighten the likelihood and
potential severity of unexpected consequences, including those emerging at later
times because of the brain’s plasticity.
Safety also is crucial when implementing
interventions for widespread clinical use
in treating brain diseases and disorders.
Safety can never be guaranteed, but risks
must be rigorously assessed and carefully
weighed against likely benefits in both research and treatment. The development
of safe interventions depends on robust
experimental design throughout the research pipeline, including adherence to
the highest standards for rigor and reproducibility. Early-stage research with nonhuman model systems must be carefully
designed to identify potential limitations
during translational phases of research.
For example, new methods of neuromodulation (invasive or otherwise) may
create unanticipated interactions and reverberating consequences. New geneediting technologies such as CRISPR/
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Table 1. Neuroethics Guiding Principles
1. Make assessing safety paramount
2. Anticipate special issues related to capacity, autonomy,
and agency
3. Protect the privacy and confidentiality of neural data
4. Attend to possible malign uses of neuroscience tools and
neurotechnologies
5. Move neuroscience tools and neurotechnologies into
medical or nonmedical uses with caution
6. Identify and address specific concerns of the public
about the brain
7. Encourage public education and dialogue
8. Behave justly and share the benefits of neuroscience
research and resulting technologies

CAS, while offering hope for mitigating or
eliminating brain disorders, are still in
their infancy and carry potential for offtarget effects. It is essential to attend to
safety data from preclinical studies and to
monitor safety throughout research when
evaluating such innovative approaches for
potential efficacy in humans. Research
participants must be thoroughly informed
of potential risks and benefits, as well as the
possibility of unexpected safety issues.
2. Anticipate special issues related to
capacity, autonomy, and agency
Contemporary neuroscience research may
enable greater understanding of brain
disorders associated with impaired, fluctuating, or diminished decision-making capacities and diminished agency (our ability
to choose our actions) and autonomy (our
ability to freely make informed choices).
Some of these disorders may present in children, in whom these characteristics are also
limited. Responsible BRAIN-funded research must study, not only “competent”
and autonomous adults, but also people
with diminished or developing autonomy
and decision-making capacity. The challenges of a fair consent process that allows
participation of those with limited, “different,” or fluctuating capacity to consent
are not new but require constant attention. For example, in research with patients with Alzheimer’s dementia, routine
assessment of how well participants receive and process information and their
decision-making ability is crucial. This
may prove especially challenging for patient participants with advanced forms of
the disease or when research involves innovative techniques that may perturb capacity in ways unfamiliar to participants.
Some interventions may lead to unanticipated changes in preferences and
agency, as in reported personality changes
after deep-brain stimulation for movement disorders (Lewis et al., 2015). In
contrast, patients with neuropsychiatric
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conditions may actively seek such alterations to enhance their agency or restore
capacities. Researchers may find themselves in the paradoxical position of seeking informed consent from participants
while at the same time manipulating neural processes necessary for consent capacity and autonomous choice. For example,
brain stimulation paradigms may target
circuits involved in reward processing and
motivation. Given our limited understanding of whether excessive stimulation
might undermine patient participants’ future decision making, how much control
regarding stimulation parameters should
go to participants in alignment with their
autonomy interests rather than to researchers? Researchers should be particularly cautious to preserve and monitor
research participants’ ability to consent,
including consent to continued participation in research.
Providing participants with accurate,
easy to understand, and evidence-based
information about potential risks and
benefits will promote well informed decisions about participation in neuroscience
research (https://www.accessdata.fda.gov/
scripts/cdrh/cfdocs/cfCFR/CFRSearch.
cfm?fr⫽50.25). Care must be taken to
avoid overpromising to possible participants, who may be desperate for a helpful intervention, and to discourage them
from believing that personal benefits are
more likely than they are.
3. Protect the privacy and
confidentiality of neural data
Research participants have a reasonable
expectation of privacy regarding their
neural data and that data’s interpretation,
which might include perceptions, emotions, memories, and thoughts. NIH
BRAIN Initiative research is developing
better methods to measure brain structure
and activity. These data will be stored for
analysis and shared often with other researchers with appropriate privacy protections to advance efforts to understand
the brain. Neural data should be treated as
private, sensitive information; its collection, transmission, and storage should adhere to best practices for security and
encryption. Conflicts may exist between
privacy/confidentiality and data sharing.
For example, large, shared databases containing brain imaging data may be extremely useful for researchers studying
both healthy and atypical brain functioning, but every brain is unique and someday a brain MRI might be as identifying as
a fingerprint. A person with access to a
shared database, as well as an individual’s

MRI, might be able to determine whether
the individual was in the database and, if
so, obtain personal information about
him or her from the “de-identified”
database.
It is important that researchers and
policymakers find ways to manage these
problems. Research participants’ confidentiality cannot be guaranteed both because of the risks of unauthorized release
of identified data through hacking and the
possibilities of re-identification. Research
participants must be given clear information about these issues and an honest
chance to decide whether to accept the
risks.
4. Attend to possible malign uses of
neuroscience tools
and neurotechnologies
Novel tools and technologies, including
neurotechnologies, can be used both for
good ends and bad. Researchers should be
mindful of possible misuses that might
range from intrusive surveillance of brain
states to efforts to incapacitate or impermissibly alter a person’s behavior. Researchers have a responsibility to try to
predict plausible misuses and ensure that
foreseeable risks are understood, as appropriate, by research participants, IRBs,
ethicists, and government officials. When
possible, misuse should be prevented, for
example, through design of the technology, such as ensuring secure wireless device connections.
5. Move neuroscience tools and
neurotechnologies into medical or
nonmedical uses with caution
BRAIN Initiative research includes cutting-edge science and first-in-human applications of novel neurotechnologies.
Accordingly, the likelihood of individual
benefit may be low and uncertain and
risks could be significant. Researchers
must thoroughly identify and minimize
potential research risks. A thoughtful justification of risks based on the potential
benefits is essential.
Hopes for neuroscience extend beyond research into exciting prospects for
novel therapeutics. In addition to safety,
researchers should consider questions of
efficacy and equity before novel neurotechnologies become widely available. Researchers and others involved in the NIH
BRAIN Initiative should discourage the
premature widespread use or inappropriate adoption of new technologies, especially those that may be offered directly to
consumers or in non-health-care settings,
such as in the legal system. For example,
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researchers looking for neural markers of
deception or pain should be aware that
segments of society may be eager to use
such tools for non-health-related ends.
Premature adoption of such tools before
accuracy is known is not appropriate.
6. Identify and address specific
concerns of the public about the brain
People care deeply about their minds and
brains and have concerns that researchers
may not sufficiently recognize. Even scientifically unjustified fears can have important consequences for public response
to neuroscience work. Although sensitivity about brain-related issues varies between cultures, three examples follow.
Fear of mental invasion reaches far
back into human history, as does the idea
of cognitive liberty—that the freedom and
privacy of one’s mind (and thus brain) is
sacrosanct. Some might have concerns
that a beneficial improvement in ability to
control the dysfunctional mind (e.g.,
from memory loss or seizures) also may
have detrimental outcomes and potentially threatens cognitive liberty (Ienca
and Andorno, 2017). Second, many people perceive their identity as being within
their brain. Novel neurointerventions
might disrupt that identity; for example,
brain implants might alter a persons’
sense of self or change their behavior in
unexpected or unwelcome ways (Gilbert
et al., 2017). Researchers should be aware
of these justified concerns that research
could “make a person someone else.” Last,
many consider the human mind and brain
to be distinguishing, perhaps definitive,
features of being human. Research with
human/nonhuman brain chimeras, neural organoids, and ex vivo human brain
tissue can provoke intellectual, visceral,
and moral concerns, including concerns
about the potential development of morally significant features in these tissues.
Researchers, funders, and others should
try to identify issues arising from their research that the public might find sensitive,
taking into account the possibility of sensationalized media reports. Both the public
and researchers will benefit if the latter consider public concerns when planning, implementing, and discussing research, as
described in the next principle.
7. Encourage public education
and dialogue
Public trust in science is a precious commodity. To the greatest extent possible,

researchers should build—and retain—
that trust by keeping the public informed.
Public dialogue should be bidirectional,
where researchers stay abreast of the public’s desires, concerns, and degree of
knowledge. Some conflicts between informing the public about research as it
proceeds and researchers’ appropriate desires to delay sharing preliminary findings
before appropriate review may be unavoidable. Nevertheless, transparency is
crucial, particularly with potentially controversial research, to avoid unduly concerning the public. Being a scientist today
requires not only good work, but also
good communication about that work.
Modern society offers scientists a wide array of ways to communicate beyond the
traditional peer-reviewed paper and academic conference talk. Good ethical stewardship of one’s work calls on scientists to
find methods that best suit them, whether
through public talks, online scholarship,
creating social media content, giving interviews, or other paths. Researchers have
an obligation to share knowledge both
about the brain and about where we continue to be ignorant about the brain’s
workings, along with possible benefits and
risks of research. University and government communications offices also have
a critical role to play in promoting
transparency.
Hyperbole is in part driven by the
imaginations of scientists, the public, and
neuroethicists and because hype about
the next great breakthrough is widely
used to hold attention. Researchers,
science journalists, communications offices, and others—including neuroethicists— have essential roles to play in
promoting appropriate understanding,
avoiding hyperbole, and correcting
overly optimistic interpretations.
8. Behave justly and share the benefits
of neuroscience research and
resulting technologies
The former Presidential Commission for
the Study of Bioethical Issues wrote “. . . a
fundamental principle of fairness suggests
that society should seek to assure that the
benefits and burdens of new technologies are shared” (https://bioethicsarchive.
georgetown.edu/pcsbi/sites/default/
files/PCSBI-Synthetic-Biology-Report12.16.10_0.pdf). Early BRAIN Initiative
studies are likely to be small and fairness
in selection of research participants is
critical because more people may want

to participate than can be included
given finite opportunities and participants with few options for treatment
may be more open to untested options.
For example, experiments testing visual
prostheses may be very appealing to persons severely affected by vision loss.
Similarly, the possible appeal of brain–
machine interface experiments for those
suffering from tetraplegia warrants
careful processes for selecting early trial
participants.
As technologies are found to be safe
and effective and enter clinical use, attention to widespread sharing of the benefits
of those technologies and interventions
will become a priority. Limited access to
safe and effective neural technologies
should not exacerbate existing health disparities or inequalities, but neither should
the burdens of research fall disproportionately on those who lack access to established interventions.

Conclusion
We offer these principles as points to
consider to help researchers and other
stakeholders better navigate the difficult
questions that the NIH BRAIN Initiative
research will pose to society. Neuroscience research holds great promise. With
that promise comes great responsibility
for diverse stakeholders to ensure both
that the promise can be fulfilled and that it
is not distorted. Neuroethics can help to
achieve this goal through published discussions, research, consultation on complex ethical issues arising from research,
the application of principles like those
herein.
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